Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

NCT06948214 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency (GHD)

Interventions

DRUG: LUM-201
OTHER: Matched Placebo (Capsules)

Sponsor

Lumos Pharma